The clinical efficacy of combined ESA and Roxadustat treatment for renal anemia in hemodialysis patients with secondary hyperparathyroidism: A case series
The combination of Roxadustat and ESAs can effectively improve renal anemia in hemodialysis patients with secondary hyperparathyroidism, as well as improve indicators of hyperparathyroidism and blood lipid levels with high levels of safety. This combined treatment thus provides a new and safe treatment method for these patients.
Authors
- Gaofeng Zheng (ORCID: https://orcid.org/0000-0003-0870-6166)
- De-zheng Chen
- M Li
- Mingli Wang (ORCID: https://orcid.org/0000-0003-3002-3855)
- Jing-jing Zhong
Institutions
- Fuyang City People's Hospital (CN)
- Deyang Stomatological Hospital (CN)
Publication Details
- Journal
- Medicine
- Published
- 2024-08-16
- DOI
- https://doi.org/10.1097/md.0000000000039083
- Citations
- 1
- Primary Topic
- Erythropoietin and Anemia Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.45